96 related articles for article (PubMed ID: 2130587)
1. Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.
Fiasse R; Druez P; Coppens JP; Delhaze M; Fabre C; Pauwels S; Dive C
Acta Gastroenterol Belg; 1990; 53(5-6):573-84. PubMed ID: 2130587
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.
Koop H; Hotz J; Pommer G; Klein M; Arnold R
Aliment Pharmacol Ther; 1990 Dec; 4(6):593-9. PubMed ID: 1983342
[TBL] [Abstract][Full Text] [Related]
4. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
5. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
[TBL] [Abstract][Full Text] [Related]
6. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
[TBL] [Abstract][Full Text] [Related]
7. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.
Holloway RH; Dent J; Narielvala F; Mackinnon AM
Gut; 1996 May; 38(5):649-54. PubMed ID: 8707107
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
10. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.
Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Meuwissen SG
Scand J Gastroenterol; 1990 Nov; 25(11):1144-50. PubMed ID: 1980377
[TBL] [Abstract][Full Text] [Related]
11. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
Koop H; Katschinski M; Arnold R
Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214
[TBL] [Abstract][Full Text] [Related]
12. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
[TBL] [Abstract][Full Text] [Related]
14. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
Brunner GH; Lamberts R; Creutzfeldt W
Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
[TBL] [Abstract][Full Text] [Related]
16. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
Dammann HG; Blum AL; Lux G; Rehner M; Riecken EO; Schiessel R; Wienbeck M; Witzel L; Berger J
Dtsch Med Wochenschr; 1986 Jan; 111(4):123-8. PubMed ID: 3510847
[TBL] [Abstract][Full Text] [Related]
17. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
[TBL] [Abstract][Full Text] [Related]
18. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
[TBL] [Abstract][Full Text] [Related]
19. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
Sharma P; Johnson DA; Monyak JT; Illueca M
Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of omeprazole in reflux oesophagitis.
Dent J; Hetzel DJ; MacKinnon MA; Reed WD; Narielvala FM
Scand J Gastroenterol Suppl; 1989; 166():76-82; discussion 94. PubMed ID: 2690334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
